v3.26.1
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2026
Restatement of Previously Issued Financial Statements [Abstract]  
Financial Statements - Restatement Reconciliation Tables
The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods indicated. The amounts in the "As Restated" columns are the updated amounts including the impacts from the restatement. Financial statement line items and subtotals that were not impacted by the restatement adjustments have been omitted for enhanced clarity.
 
Balance Sheet – as of December 31, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Deferred tax assets, net
 $-    $58,709   $58,709 
Total assets
  26,237,315    58,709    26,296,024 
                
Accrued expenses
  2,160,366    1,907,251    4,067,617 
Total current liabilities
  13,293,479    1,907,251    15,200,730 
Deferred tax liabilities, net
  355,646    (355,646)     -  
Total liabilities
  13,883,222    1,551,605    15,434,827 
                
Accumulated deficit
  (18,054,278)    (1,492,896)    (19,547,174) 
Total stockholders’ equity
 $12,354,093   $(1,492,896)   $10,861,197 
 
Statement of Operations – Three Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Selling, general, and administrative expenses  $2,627,168   $129,713   $2,756,881 
Total operating expenses   4,938,272    129,713    5,067,985 
Income from operations   121,270    (129,713)    (8,443) 
Other income, net   179,684    (25,886)    153,798 
Income before income taxes   300,954    (155,599)    145,355 
Provision for income taxes   (71,427)    61,513    (9,914) 
Net income   229,527    (94,086)    135,441 
                
Net income per share – Basic and diluted  $0.02    (0.01)   $0.01 
Statement of Operations - Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Selling, general, and administrative expenses
 $5,104,119   $266,308   $5,370,427 
Total operating expenses
  9,784,317    266,308    10,050,625 
Income from operations
  146,638    (266,308)    (119,670) 
Other income, net
  360,516    (48,852)    311,664 
Income before income taxes
  507,154    (315,160)    191,994 
Provision for income taxes
  (118,565)    54,203    (64,362) 
Net income
  388,589    (260,957)    127,632 
                
Net income per share – Basic and diluted
 $0.04   $(0.03)   $0.01 
 
Statements of Stockholders' Equity – Three Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Balance as of April 1, 2025
              
Accumulated deficit
 $(18,913,147)   $(1,152,997)   $(20,066,144) 
Total stockholders’ equity
  11,328,093    (1,152,997)    10,175,096 
                
Balance as of June 30, 2025
              
Accumulated deficit
  (18,683,620)    (1,247,083)    (19,930,703) 
Total stockholders’ equity
 $11,677,738   $(1,247,083)   $10,430,655 
 
Statements of Stockholders' Equity – Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Balance as of January 1, 2025
              
Accumulated deficit
 $(19,072,209)   $(986,126)   $(20,058,335) 
Total stockholders’ equity
  11,141,746    (986,126)    10,155,620 
                
Balance as of June 30, 2025
              
Accumulated deficit
  (18,683,620)    (1,247,083)    (19,930,703) 
Total stockholders’ equity
 $11,677,738   $(1,247,083)   $10,430,655 
Statement of Cash Flows –Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Six Months Ended June 30, 2025
              
Cash flows from operating activities:
              
Net income
 $388,589   $(260,957)   $127,632 
Changes in operating assets and liabilities:
              
Accrued expenses
 $(263,634)   $260,957   $(2,677)